ACVR2A and neoplasm: Consistent with this we also identify alterations in the ACVR2A gene that encodes for an activin/BMP receptor enriched in this tumour group, which is also downregulated during tumour progression (Fig. 7B and Supplementary Fig. 11) implying a tumour suppressor role for this gene.